Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |